TAT and ischemia: As exemplified with ψ-GSH and Tat-Glo delivery in the context of AD and ischemia, strategies aiming to re-establish or boost the glyoxalase system efficiency will therefore represent potentially powerful therapeutically approaches for MG-associated brain pathologies.